1. Mayaro Virus Pathogenesis and Transmission Mechanisms
- Author
-
Julien Pompon, Rodolphe Hamel, Michèle Bengue, Cheikh Tidiane Diagne, Dorothée Missé, Valérie Choumet, Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Environnement et Risques infectieux - Environment and Infectious Risks (ERI), Institut Pasteur [Paris] (IP), Interhuman Arbovirus Transmission (MIVEGEC-iHAT), Biologie des infections virales: Emergence, DIFfusion, Impact, Contrôle, Elimination (EDIFICE), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), This work was supported by the Méditerranée Infection Foundation and was publicly funded by theFrench National Research Agency (ANR-15-CE15-00029), and Institut Pasteur [Paris]
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,030231 tropical medicine ,competence ,lcsh:Medicine ,emerging arbovirus ,Mayaro ,Alphavirus ,Disease ,Review ,03 medical and health sciences ,0302 clinical medicine ,Aedes ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Epidemiology ,medicine ,Togaviridae ,Immunology and Allergy ,alphavirus ,Molecular Biology ,vector competence ,General Immunology and Microbiology ,biology ,Transmission (medicine) ,Public health ,lcsh:R ,Outbreak ,biology.organism_classification ,Virology ,3. Good health ,Mosquito control ,030104 developmental biology ,Infectious Diseases ,Geography ,Aedes vector - Abstract
International audience; Mayaro virus (MAYV), isolated for the first time in Trinidad and Tobago, has captured the attention of public health authorities worldwide following recent outbreaks in the Americas. It has a propensity to be exported outside its original geographical range, because of the vast distribution of its vectors. Moreover, most of the world population is immunologically naïve with respect to infection with MAYV which makes this virus a true threat. The recent invasion of several countries by Aedes albopictus underscores the risk of potential urban transmission of MAYV in both tropical and temperate regions. In humans, the clinical manifestations of MAYV disease range from mild fever, rash, and joint pain to arthralgia. In the absence of a licensed vaccine and clinically proven therapeutics against Mayaro fever, prevention focuses mainly on household mosquito control. However, as demonstrated for other arboviruses, mosquito control is rather inefficient for outbreak management and alternative approaches to contain the spread of MAYV are therefore necessary. Despite its strong epidemic potential, little is currently known about MAYV. This review addresses various aspects of MAYV, including its epidemiology, vector biology, mode of transmission, and clinical complications, as well as the latest developments in MAYV diagnosis.
- Published
- 2020